Gastric Burkitt's monomorphic post-transplant lymphoproliferative disorder after kidney transplantation: A case report

Clin Nephrol. 2024 May;101(5):250-256. doi: 10.5414/CN111321.

Abstract

We report on a 53-year-old Japanese man diagnosed with gastric Burkitt's monomorphic post-transplant lymphoproliferative disorder (B-PTLD) after endoscopy for gastric discomfort 28 months after the patient underwent renal transplantation in Ethiopia. Serum Epstein-Barr virus (EBV) tests were negative before transplantation, but the tumor cells collected from a gastric biopsy showed positive EBV-encoded small RNAs (EBER) at B-PTLD onset. Intensive treatment started with R(rituximab)-CHOP therapy and continued with DA-EPOCH-R therapy has been effective, and relapse has not yet occurred. Burkitt lymphoma has a poor prognosis, but B-PTLD may be effectively treated with high-dose chemotherapy. This is a rare case of gastric B-PTLD in a Japanese patient.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Epstein-Barr Virus Infections* / complications
  • Epstein-Barr Virus Infections* / diagnosis
  • Herpesvirus 4, Human
  • Humans
  • Kidney Transplantation* / adverse effects
  • Lymphoproliferative Disorders* / diagnosis
  • Lymphoproliferative Disorders* / drug therapy
  • Lymphoproliferative Disorders* / etiology
  • Male
  • Middle Aged
  • Rituximab / therapeutic use

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab